1MRKX:BIT
Merck & Co.
128,18 €
arrow_downward
-0,59%(-0,76) 1Η
2 Οκτ, 5:26:00 μ.μ. GMT+2 · EUR
search
Όλα τα σύμβολα
| Σύμβολο | Τιμή | Μεταβολή | Ποσοστιαία μεταβολή |
|---|
Ειδήσεις
Από πηγές ιστού και συνεργάτες ειδήσεων
MarketBeat
·
πριν από 6 ώρες
48,205 Merck & Co., Inc. $MRK Shares Sold by Courier Capital LLC
Yahoo Finance
·
πριν από 11 ώρες
Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
The Pharma Letter
·
πριν από 14 ώρες
Nimbus hires Merck & Co dealmaker as chief business officer
Simply Wall Street
·
πριν από 14 ώρες
Merck (MRK) Stock Could Be A Bargain As Its 120% Run Continues
Προφίλ
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia